A panel of ophthalmologists defined points of consensus for suprachoroidal space injections based on current published evidence. IVT is the primary method of delivering therapeutics in the eye, ...
LEXINGTON, Mass. - Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), a clinical-stage biotech company with a market capitalization of $211 million, has received a Special Protocol Assessment Agreement Letter ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する